FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eleni Efstathiou

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Panagiotis Mourmouris; Eleni Efstathiou; Athanasios Papatsoris
Androgen deprivation therapy and cardiovascular risk.
Eleni Efstathiou; Anh Hoang; Maria Karlou; Sankar Maity; Curtis A Pettaway; Louis L Pisters; Patricia Troncoso; Sijin Wen; Christopher J Logothetis
Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers.
Christopher J Logothetis; Paul N Mainwaring; Arturo Molina; Scott A North; Margaret Rothman; Howard I Scher; Cora N Sternberg; Ethan Basch; Kim N Chi; Eleni Efstathiou; Karim Fizazi; Dennis D Gagnon; Oscar B Goodman; Yanni Hao; Christopher M Haqq; Robert J Jones; Thian S Kheoh; Cameron S Liu; Johann S de Bono
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eleni Efstathiou (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Panagiotis Mourmouris; Eleni Efstathiou; Athanasios Papatsoris
Androgen deprivation therapy and cardiovascular risk.
Nephro-urology monthly 2013;5(1):653-4.
2013: Eleni Efstathiou; Anh Hoang; Maria Karlou; Sankar Maity; Curtis A Pettaway; Louis L Pisters; Patricia Troncoso; Sijin Wen; Christopher J Logothetis
Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers.
The Prostate 2013;73(2):153-61.
2012: Christopher J Logothetis; Paul N Mainwaring; Arturo Molina; Scott A North; Margaret Rothman; Howard I Scher; Cora N Sternberg; Ethan Basch; Kim N Chi; Eleni Efstathiou; Karim Fizazi; Dennis D Gagnon; Oscar B Goodman; Yanni Hao; Christopher M Haqq; Robert J Jones; Thian S Kheoh; Cameron S Liu; Johann S de Bono
Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.
The lancet oncology 2012;13(12):1210-7.
2012: Stavros Dimopoulos; Christos Charitos; Evagelos Eleftherakis; Evagelos Kostis; Timotheos Sakellaridis; Dimitrios Sinapidis; Savvas T Toumanidis; Eleni Efstathiou
Bartonella quintana endocarditis as a cause of severe aortic insufficiency and heart failure.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē 2012;53(6):476-9.
2012: Maria Karlou; Christopher J Logothetis; Jing-Fang Lu; Sankar Maity; Nora M Navone; Vassiliki Tzelepi; Guanglin Wu; Anh Hoang; Eleni Efstathiou
Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.
The Prostate 2012;72(15):1638-47.
2012: Avik Som; Li Xiao; Rui Zhu; Eleni Efstathiou; Charles C Guo; Angabin Matin; Louis L Pisters; Shi-Ming Tu
Recurrent seminomas: clinical features and biologic implications.
Urologic oncology 2012;30(4):494-501.
2012: Kanishka Sircar; Patricia Troncoso; Vassiliki Tzelepi; Ana Aparicio; Tarek A Bismar; David Cogdell; Jasreman Dhillon; Eleni Efstathiou; Limei Hu; Heng Huang; Ismaël H Koumakpayi; Dijun Luo; Nora M Navone; Fred Saad; Wei Zhang
Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.
The American journal of pathology 2012;180(3):895-903.
2012: Eleni Efstathiou; Anh Hoang; Maria Karlou; Arturo Molina; Lisa A Smith; Mark Titus; Patricia Troncoso; Dimitra Tsavachidou; Vassiliki Tzelepi; Sijin Wen; Nicole Chieffo; Christopher J Logothetis
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(6):637-43.
2012: Xinhai Wan; Jing Wang; Jun Yang; Lixia Diao; Eleni Efstathiou; Jie Liu; Jing-Fang Lu; Sankar N Maity; Michael W Starbuck; Patricia Troncoso; Vassiliki Tzelepi; Elba S Vazquez; Nora M Navone
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(3):726-36.
2012: Vassiliki Tzelepi; Xinhai Wan; Guanglin Wu; Jiexin Zhang; Eleni Efstathiou; Anh Hoang; Brittany Kleb; Shoudan Liang; Christopher J Logothetis; Jing-Fang Lu; Sankar N Maity; Nora M Navone; Kanishka Sircar; Patricia Troncoso; Ana M Aparicio
Modeling a lethal prostate cancer variant with small-cell carcinoma features.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(3):666-77.
2012: Kanishka Sircar; Patricia Troncoso; Armen G Aprikian; David Cogdell; Jasreman Dhillon; Eleni Efstathiou; Limei Hu; Heng Huang; Yuexin Liu; Nora M Navone; Wei Zhang
Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer.
PloS one 2012;7(2):e31259.
2011: Vassiliki Tzelepi; Sijin Wen; Curtis A Pettaway; Louis L Pisters; Patricia Troncoso; Eleni Efstathiou; Anh Hoang; Maria Karlou; Christopher J Logothetis; Lance C Pagliaro
Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(18):2574-81.
2011: Vassiliki Tzelepi; Sijin Wen; Anh Hoang; Maria Karlou; Christopher Logothetis; Patricia Troncoso; Eleni Efstathiou
Expression of hedgehog pathway components in prostate carcinoma microenvironment: shifting the balance towards autocrine signalling.
Histopathology 2011;58(7):1037-47.
2011: Evangelos Bournakis; Eleni Efstathiou; Andreas Varkaris; Sijin Wen; Michael Chrisofos; Charalambos Deliveliotis; Christos Alamanis; Ioannis Anastasiou; Constantinos Constantinides; Aristotelis Bamias; Meletios A Dimopoulos
Time to castration resistance is an independent predictor of castration-resistant prostate cancer survival.
Anticancer research 2011;31(4):1475-82.
2011: Ioannis Mountzios; Evangelos Bournakis; Eleni Efstathiou; Andreas Varkaris; Sijin Wen; Michael Chrisofos; Charalambos Deliveliotis; Christos Alamanis; Ioannis Anastasiou; Constantinos Constantinides; Alexandra Karadimou; Marinos Tsiatas; Christos Papadimitriou; Aristotelis Bamias; Meletios A Dimopoulos
Intermittent docetaxel chemotherapy in patients with castrate-resistant prostate cancer.
Urology 2011;77(3):682-7.
2010: Evangelos Eleutherakis-Papaiakovou; Evangelos Kostis; Magda Migkou; Dimitrios Christoulas; Evangelos Terpos; Maria Gavriatopoulou; Maria Roussou; Evangelos Bournakis; Efstathios Kastritis; Eleni Efstathiou; Meletios A Dimopoulos; Christos A Papadimitriou
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
American journal of hematology 2010;85(11):863-7.
2010: Meletios A Dimopoulos; Efstathios Kastritis; D Christoulas; M Migkou; M Gavriatopoulou; M Gkotzamanidou; M Iakovaki; Charis Matsouka; D Mparmparoussi; Maria Roussou; Eleni Efstathiou; Evangelos Terpos
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.
Leukemia 2010;24(10):1769-78.
2010: Meletios A Dimopoulos; Dimitrios Christoulas; Maria Roussou; Efstathios Kastritis; Magdalini Migkou; Maria Gavriatopoulou; Charis Matsouka; Despoina Mparmparoussi; Erasmia Psimenou; Irini Grapsa; Eleni Efstathiou; Evangelos Terpos
Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.
European journal of haematology 2010;85(1):1-5.
2010: Eleni Efstathiou; Christopher J Logothetis
A new therapy paradigm for prostate cancer founded on clinical observations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(4):1100-7.
2009: Evangelos Terpos; Eleni Efstathiou; Dimitrios Christoulas; Maria Roussou; Eirini Katodritou; Meletios-Athanassios Dimopoulos
RANKL inhibition: clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases.
Expert opinion on biological therapy 2009;9(4):465-79.
2008: Christos Papadimitriou; U Dafni; Athanasios Anagnostopoulos; George Vlachos; Zannis Voulgaris; Alexandros Rodolakis; Gerasimos Aravantinos; Aristotelis Bamias; George Bozas; E Kiosses; G M Gourgoulis; Eleni Efstathiou; Meletios A Dimopoulos
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial.
Bone marrow transplantation 2008;41(6):547-54.
2007: George Bozas; Aristotelis Bamias; Vassiliki Koutsoukou; Eleni Efstathiou; Dimitra Gika; Christos A Papadimitriou; Meletios A Dimopoulos
Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma.
Gynecologic oncology 2007;104(3):580-5.
2007: Eleni Efstathiou; Meletios A Dimopoulos; George Bozas; Efstathios Kastritis; Lia A Moulopoulos; Alexandros Rodolakis; George Vlahos; Dimitra Gika; Christos Papadimitriou; Aristotelis Bamias
Advanced epithelial ovarian cancer in the elderly: chemotherapy tolerance and outcome.
Anticancer research 2007;27(1B):611-7.
2006: Davide Mauri; George Pentheroudakis; Dimitrios Bafaloukos; Dimitrios Pectasides; Epaminondas Samantas; Eleni Efstathiou; Haralabos P Kalofonos; Konstantinos Syrigos; George Klouvas; Pavlos Papakostas; Paris A Kosmidis; George Fountzilas; Nicholas Pavlidis
Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
Anticancer research 2006;26(4B):3175-81.
2006: Efstathios Kastritis; Eleni Efstathiou; Dimitra Gika; George Bozas; Vassiliki Koutsoukou; Christos Papadimitriou; George Pissakas; Meletios A Dimopoulos; Aristotelis Bamias
Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16(3):994-9.
2006: Aristotelis Bamias; Christos Papadimitriou; Eleni Efstathiou; Alexandros Rodolakis; George Vlahos; Zannis Voulgaris; George Bozas; George Fountzilas; Gerasimos Aravantinos; Evangelia Razis; Dimitra Gika; Meletios A Dimopoulos
Four cycles of paclitaxel and carboplatin as adjuvant treatment in early-stage ovarian cancer: a six-year experience of the Hellenic Cooperative Oncology Group.
BMC cancer 2006;6():228.
2006: George Bozas; Meletios A Dimopoulos; Efstathios Kastritis; Eleni Efstathiou; Vassiliki Koutsoukou; Alexandros Rodolakis; George Vlahos; Zannis Voulgaris; Theoharis Papageorgiou; Dimitra Gika; Christos Papadimitriou; Aristotelis Bamias
Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience.
Oncology 2006;70(4):265-72.
2005: Amanda Psyrri; Aristotelis Bamias; Ziwei Yu; Paul Weinberger; Mohamad Kassar; Sonia Markakis; Diane Kowalski; Eleni Efstathiou; Robert L Camp; David L Rimm; Meletios A Dimopoulos
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(23):8384-90.
2005: Efstathios Kastritis; Aristotelis Bamias; Eleni Efstathiou; Dimitra Gika; George Bozas; P Zorzou; Kyrillos Sarris; Christos Papadimitriou; Meletios A Dimopoulos
The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy.
Gynecologic oncology 2005;99(2):376-82.
2005: Dimitrios Pectasides; Gerasimos Aravantinos; George Fountzilas; Charalambos Kalofonos; Eleni Efstathiou; Maria Karina; Nicholas Pavlidis; Dimitrios Farmakis; Theofanis Economopoulos; Meletios A Dimopoulos
Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.
Anticancer research 2005;25(5):3553-8.
2005: Georgios Chamilos; Aristotelis Bamias; Eleni Efstathiou; Pagona M Zorzou; Efstathios Kastritis; Evagelos Kostis; Christos Papadimitriou; Meletios A Dimopoulos
Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
Cancer 2005;103(12):2629-35.
2005: Dimitrios Bafaloukos; Dimosthenis A Tsoutsos; Haralambos Kalofonos; S Chalkidou; Petros Panagiotou; E Linardou; Evangelos Briassoulis; Eleni Efstathiou; Aristidis Polyzos; George Fountzilas; Christos Christodoulou; Charalambos Kouroussis; Thomais Iconomou; Helen Gogas
Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(6):950-7.
2005: Dimitrios Pectasides; George Fountzilas; Gerasimos Aravantinos; Haralabos P Kalofonos; Eleni Efstathiou; Emmanuel Salamalekis; Dimitrios Farmakis; Dimosthenis Skarlos; Evangelos Briasoulis; Theofanis Economopoulos; Meletios A Dimopoulos
Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
Gynecologic oncology 2005;97(2):436-41.
2005: Nikolaos Xiros; P Papacostas; Theofanis Economopoulos; Georgios Fotios Samelis; Eleni Efstathiou; Efstathios Kastritis; Haralambos Kalofonos; Adimchi Onyenadum; Dimosthenis Skarlos; Aristotelis Bamias; Helen Gogas; Dimitrios Bafaloukos; Epaminondas Samantas; Paris A Kosmidis
Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):773-9.
2005: Markela P Zorzou; Eleni Efstathiou; Eleni Galani; George Bozas; Efstathios Kastritis; Christos Papadimitriou; Meletios A Dimopoulos; Aristotelis Bamias
Carboplatin hypersensitivity reactions: a single institution experience.
Journal of chemotherapy (Florence, Italy) 2005;17(1):104-10.
2005: Aristotelis Bamias; Eleni Efstathiou; Lia A Moulopoulos; Dimitra Gika; George Hamilos; Markela P Zorzou; C Kakoyiannis; Efstathios Kastritis; George Bozas; Christos Papadimitriou; Meletios A Dimopoulos
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(2):307-13.
2005: Aristotelis Bamias; Eleni Efstathiou; M Vassilakopoulou; Vassiliki Koutsoukou; Christos Papadimitriou; Alexandros Rodolakis; Dimitrios Mitsibounas; George Vlahos; Meletios A Dimopoulos
Late relapse of epithelial ovarian cancer: a single institution experience.
European journal of gynaecological oncology 2005;26(4):439-42.
2005: Eleni Efstathiou; George Bozas; Athanasios Kostakopoulos; Efstathios Kastritis; Charalambos Deliveliotis; Nikolaos Antoniou; Dimosthenis Skarlos; Christos Papadimitriou; Meletios A Dimopoulos; Aristotelis Bamias
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment.
Urology 2005;65(1):126-30.
2004: Meletios A Dimopoulos; Christos Papadimitriou; George Hamilos; Eleni Efstathiou; George Vlahos; Alexandros Rodolakis; Gerasimos Aravantinos; Haralambos Kalofonos; Charalambos Kouroussis; Dimitra Gika; Dimosthenis Skarlos; Aristotelis Bamias
Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Gynecologic oncology 2004;95(3):695-700.
2004: Helena Linardou; Gerasimos Aravantinos; Eleni Efstathiou; Charalambos Kalofonos; Athanasios Anagnostopoulos; Charalambos Deliveliotis; Dimitrios Bafaloukos; Meletios Athanasios Dimopoulos; Aristotelis Bamias
Gemcitabine and carboplatin combination as first-line treatment in elderly patients and those unfit for cisplatin-based chemotherapy with advanced bladder carcinoma: Phase II study of the Hellenic Co-operative Oncology Group.
Urology 2004;64(3):479-84.
2004: Ioanna Dimopoulou; Eleni Efstathiou; A Samakovli; Urania Dafni; Lia A Moulopoulos; Christos Papadimitriou; Panagiotis Lyberopoulos; Efstathios Kastritis; C Roussos; M A Dimopoulos
A prospective study on lung toxicity in patients treated with gemcitabine and carboplatin: clinical, radiological and functional assessment.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1250-5.
2004: Markella-Pagona Zorzou; Alexander J Stratigos; Eleni Efstathiou; Aristotelis Bamias
Exacerbation of psoriasis after treatment with an EGFR tyrosine kinase inhibitor.
Acta dermato-venereologica 2004;84(4):308-9.
2004: Christos A Papadimitriou; Sophia Markaki; John Siapkaras; George Vlachos; Eleni Efstathiou; Irene Grimani; George Hamilos; Markela P Zorzou; Meletios A Dimopoulos
Hormonal therapy with letrozole for relapsed epithelial ovarian cancer. Long-term results of a phase II study.
Oncology 2004;66(2):112-7.
2004: Meletios A Dimopoulos; George Hamilos; Athanasios Zomas; Dimitra Gika; Eleni Efstathiou; Vassiliki Grigoraki; Christos Poziopoulos; Irini Xilouri; Markela P Zorzou; Nikolaos Anagnostopoulos; Athanasios Anagnostopoulos
Pulsed cyclophosphamide, thalidomide and dexamethasone: an oral regimen for previously treated patients with multiple myeloma.
The hematology journal : the official journal of the European Haematology Association / EHA 2004;5(2):112-7.
2003: Meletios A Dimopoulos; George Hamilos; Eleni Efstathiou; Ioannis Siapkaras; Charis Matsouka; Dimitra Gika; Vassiliki Grigoraki; Christos Papadimitriou; Dimitrios Mitsibounas; Nikolaos Anagnostopoulos
Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
Leukemia & lymphoma 2003;44(6):993-6.
2003: Christos Kroupis; Evi S Lianidou; Nikos Goutas; Angela Ladopoulou; Irene Konstantopoulou; Alexandros Pantazidis; Drakoulis Yannoukakos; Eleni Efstathiou; Nikos Vourlidis; Christina Tsionou
Atypical medullary breast carcinoma in a family carrying the 5382insC BRCA-1 mutation.
The breast journal 2003;9(3):260-2.
2002: Meletios A Dimopoulos; Constantinos Zervas; Athanasios Zomas; George Hamilos; Dimitra Gika; Eleni Efstathiou; Panayiotis Panayiotidis; Elisavet-Christine Vervessou; Nikolaos Anagnostopoulos; John Christakis
Extended rituximab therapy for previously untreated patients with Waldenström's macroglobulinemia.
Clinical lymphoma 2002;3(3):163-6.
2002: Angela Ladopoulou; Christos Kroupis; Irene Konstantopoulou; L Ioannidou-Mouzaka; Andrew C Schofield; Alexandros Pantazidis; Sophia Armaou; I Tsiagas; Evi S Lianidou; Eleni Efstathiou; Christina Tsionou; Christos Panopoulos; Markos Mihalatos; Georgios Nasioulas; Dimosthenis Skarlos; Neva E Haites; George Fountzilas; Nikos Pandis; Drakoulis Yannoukakos
Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed.
Cancer letters 2002;185(1):61-70.
2002: Meletios A Dimopoulos; Christos A Papadimitriou; Kyrillos Sarris; Gerasimos Aravantinos; Charalambos Kalofonos; Dimitra Gika; Georgios M Gourgoulis; Eleni Efstathiou; Dimosthenis Skarlos; Dimitrios Bafaloukos
Combination of ifosfamide, paclitaxel, and cisplatin for the treatment of metastatic and recurrent carcinoma of the uterine cervix: a phase II study of the Hellenic Cooperative Oncology Group.
Gynecologic oncology 2002;85(3):476-82.
2002: Angela Ladopoulou; Irene Konstantopoulou; Sophia Armaou; Eleni Efstathiou; Markos Mihalatos; Georgios Nasioulas; Georgia Bardi; Nikos Pandis; Drakoulis Yannoukakos
A change in the last base of BRCA1 exon 23, 5586G-->A, results in abnormal RNA splicing.
Cancer genetics and cytogenetics 2002;134(2):175-7.
2002: Christos Christodoulou; George Klouvas; Eleni Efstathiou; D Zervakis; E Papazachariou; M Plyta; Dimosthenis V Skarlos
Effectiveness of the MSC cold cap system in the prevention of chemotherapy-induced alopecia.
Oncology 2002;62(2):97-102.
2000: Irene Konstantopoulou; Christos Kroupis; Angela Ladopoulou; Alexandros Pantazidis; D Boumba; Evi S Lianidou; Michael B Petersen; L Florentin; Efstratios Chiotellis; George Nounesis; Eleni Efstathiou; Dimosthenis Skarlos; Christina Tsionou; George Fountzilas; Drakoulis Yannoukakos
BRCA1 mutation analysis in breast/ovarian cancer families from Greece.
Human mutation 2000;16(3):272-3.
2000: Jim Janinis; Eleni Efstathiou; Christos Panopoulos; Epaminondas Samantas; Gerasimos Aravantinos; Christos Christodoulou; Dimosthenis Skarlos
Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status.
Medical oncology (Northwood, London, England) 2000;17(2):106-10.